טוען...
Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)
Intravenous immunoglobulin (IVIG), a pooled normal IgG from several thousand healthy donors and one of the commonly used immunotherapeutic molecules for the management of autoimmune and inflammatory diseases, has been explored for the treatment of coronavirus disease‐19 (COVID‐19). Although placebo‐...
שמור ב:
| הוצא לאור ב: | Clin Transl Immunology |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7565103/ https://ncbi.nlm.nih.gov/pubmed/33088506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1198 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|